Spire Healthcare Offers Gardasil Cervical Cancer Vaccine at Washington Hospital

Share Article

Spire Healthcare now offers Gardasil, the cervical cancer vaccine, at its Washington Hospital.

Spire Healthcare's Washington Hospital will now offer Gardasil, the vaccine that can protect young women from most forms of cervical cancer. The vaccine has been welcomed as a hugely important medical advance in the treatment of one of the major forms of cancer in women.

Gardasil protects against four strains of the human papilloma virus (HPV) which can lead to cervical cancer as well as genital warts and pre-cancerous lesions. Two of these cause 70% of cervical cancer cases with the other two causing 90% of genital warts.

On average 3,000 women per year are diagnosed with cervical cancer in Britain. This amounts to 3 deaths per day in women under the age of 44.

Spire consultant gynaecologist, Mr Craig Steele, commented "The Gardasil vaccine is a huge step forward in the fight to protect women from cervical cancer."

The vaccine works best in those who have not been exposed to any strains of HPV, and so is most widely recommended for females who are not yet sexually active. Medical trials have shown that it is also effective in women up to the age of 26.

Gardasil is given in 3 separate injections over a six month period and costs £360. The price includes an initial consultation with a consultant gynaecologist and 3 injections.

To find out more or arrange an appointment please contact Spire's out-patient team at the Washington Hospital on 0191 418 8636 or 418 8664 or visit http://www.spirehealthcare.com/.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Charlotte Walker
Visit website